European Archives - Page 440 of 1590 - European Medical Journal

Spike in Hepatitis A Cases Hits Vulnerable Communities in Central Europe

Europe faces a sharp rise in hepatitis A cases, with over 2,000 infections in 2025. Vulnerable groups are most affected as ECDC urges vaccination and sanitation efforts.

Pfizer’s Richard Maughan on the future of access in the UK

Richard Maughan, Senior Director and Head of UK Policy and Public Affairs, Pfizer, explores how the UK is shaping access to medicine.

TikTok Skincare Trends Risk Harming Young Skin

Discover a study where two investigators, using new TikTok accounts registered as 13-year-olds, collected and analysed the videos through the platform’s “For You” tab.

Smoking Linked to Delayed Prostatectomy Recovery

Discover a recent study that found that smoking is associated with worse sexual function outcomes following radical prostatectomy.

EAN 2025: ChatGPT-4o Rivals Neurology Experts in Diagnosing and Managing Polyneuropathy

AI tool GPT-4o boosts diagnosis accuracy for nerve disorders, helping non-specialists match expert recommendations in real cases.

Environmental and Social Stressors Accelerate Ageing in Patients with Lung Disease

Air pollution and poverty accelerate ageing and worsen survival in fibrotic lung disease patients, new international epigenetic study reveals.

Drug-Coated Balloons in Percutaneous Coronary Interventions

Paclitaxel stabilises microtubules and arrests the cell cycle at the G2/M phase, leading to cell death,15,16 which thereby suppresses…

Cardiac MRI Enhances Risk Stratification in HFpEF Through RV Strain Metrics

Understand how MRI-derived RV strain predicts outcomes in HFpEF, offering improved risk stratification over traditional metrics.

EAN 2025: Nightmares Linked to Faster Ageing and Premature Mortality

Frequent nightmares accelerate ageing and triple risk of early death, highlighting a new target for preventive healthcare.

Fexuprazan Found as Effective as PPI for Chronic Cough in Patients with GORD

Learn how P-CAB fexuprazan matches PPI effectiveness in managing GERD-related chronic cough in an 8-week clinical trial.